Overview
Hypertrophic cardiomyopathy (HCM) is a complex condition that affects the heart muscle, making it thicker and less efficient. This abnormal thickening can lead to a range of symptoms, from mild to severe, and can increase the risk of sudden cardiac death. HCM is the most common cause of sudden cardiac death in young athletes, and it is estimated to affect approximately 1 in 500 people worldwide.
HCM is a genetic disorder, meaning it is inherited from one's parents. The condition is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. These mutations can lead to abnormal thickening of the heart walls, which can disrupt the normal functioning of the heart. In some cases, HCM can also be caused by other factors, such as high blood pressure or certain medications.
History/Background
The first descriptions of HCM date back to the 19th century, when physicians noted the presence of abnormal heart muscle thickening in patients with sudden cardiac death. However, it wasn't until the 1960s that the condition was formally described and named "hypertrophic cardiomyopathy." Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of diagnostic and treatment options.
Key Information
* Prevalence: HCM affects approximately 1 in 500 people worldwide.
* Genetics: HCM is a genetic disorder, with mutations in genes such as MYH7, MYBPC3, and TNNT2.
* Symptoms: Symptoms of HCM can range from mild to severe and may include shortness of breath, chest pain, fainting, and palpitations.
* Complications: HCM can lead to life-threatening complications, including sudden cardiac death, heart failure, and arrhythmias.
* Diagnosis: Diagnosis of HCM typically involves a combination of physical examination, electrocardiogram (ECG), echocardiogram, and genetic testing.
* Treatment: Treatment options for HCM include medications to manage symptoms, implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death, and surgical procedures to reduce the thickness of the heart muscle.
Significance
HCM is a significant condition that requires prompt attention and management. The risk of sudden cardiac death in individuals with HCM is estimated to be 1-2% per year, making it a major public health concern. Early diagnosis and treatment can significantly improve outcomes and reduce the risk of complications. In addition, advances in genetic testing and personalized medicine have improved our understanding of HCM and enabled more effective management of the condition.
